GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded end point (PROBE) trial

  • Byron Cryer, Chunming Li, Lee S Simon, Gurkirpal Singh, Martin J Stillman, Manuela Berger
  • Arthritis Research & Therapy, February 2012, Springer Science + Business Media
  • DOI: 10.1186/ar3664

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Martin Stillman